Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory, Double-Blind, Randomized, Placebo Controlled Study Evaluating Topical Recombinant Human Vascular Endothelial Growth Factor (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers

NCT00069446 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT00069446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00069446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory, Double-Blind, Randomized, Placebo Controlled Study Evaluating Topical Recombinant Human Vascular Endothelial Growth Factor (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers
Lead sponsor
Genentech, Inc.
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2003
Completion date
October 31, 2004
Enrollment
50
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

foot ulcer